An increased expression of Magmas has been noted in prostate cancer [37], glioblastomas [38], triple-negative breast cancers [39], neuroendocrine prostate cancers [40], and recently, in ovarian cancer [41]. This evidence concerns the gene PAM16 and prostate cancer.